共 50 条
- [1] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
- [3] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
- [4] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
- [5] A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guerin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder [J]. JOURNAL OF UROLOGY, 2020, 204 (02): : 247 - 253
- [6] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
- [10] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72